Evaluation of copper complexes as potential anti-arthritic drugs.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology; D003300:Copper / Q000008:administration & dosage / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000187:drug effects; D007279:Injections, Subcutaneous; D007509:Irritants; D051381:Rats; D012459:Salicylates / Q000008:administration & dosage / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D007509:Irritants; D012459:Salicylates; D003300:Copper; D001241:Aspirin